Draft:OM Pharma: Difference between revisions
Mestudillo (talk | contribs) mNo edit summary |
Mestudillo (talk | contribs) No edit summary |
||
| Line 13: | Line 13: | ||
| key_people = {{ublist |Roch Ogier (CEO)|Sandrine Bertrand (Chief Technical Officer)|Patricia Licata (Chief Human Resources & Communication Officer)|Laurent Perritaz (Chief Financial Officer)|Pascal Schumacher (Chief Commercial Officer)|Anna Thomas (Chief Scientific Officer)}} |
| key_people = {{ublist |Roch Ogier (CEO)|Sandrine Bertrand (Chief Technical Officer)|Patricia Licata (Chief Human Resources & Communication Officer)|Laurent Perritaz (Chief Financial Officer)|Pascal Schumacher (Chief Commercial Officer)|Anna Thomas (Chief Scientific Officer)}} |
||
| products = {{ublist|[[Triptorelin]]|[[Oxaliplatin]]}} |
| products = {{ublist|[[Triptorelin]]|[[Oxaliplatin]]}} |
||
| owner = [[Etienne Jornod (Executive Chairman & Co‑Owner) |
| owner = [[Etienne Jornod]] (Executive Chairman & Co‑Owner) |
||
| homepage = [http://www.ompharma.com/ www.ompharma.com] |
| homepage = [http://www.ompharma.com/ www.ompharma.com] |
||
}} |
}} |
||
Revision as of 12:17, 17 October 2024
 | Draft article not currently submitted for review.
This is a draft Articles for creation (AfC) submission. It is not currently pending review. While there are no deadlines, abandoned drafts may be deleted after six months. To edit the draft click on the "Edit" tab at the top of the window. To be accepted, a draft should:
It is strongly discouraged to write about yourself, your business or employer. If you do so, you must declare it. Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
Last edited by Mestudillo (talk | contribs) 2 months ago. (Update) |
 | |
| Company type | Société Anonyme |
|---|---|
| Industry | Biopharmaceutical |
| Founded | XXXX, Switzerland (1979) |
| Founder | Jean-René Ricard (1922-2017) |
| Headquarters | Geneva, Switzerland |
Area served | Worldwide |
Key people |
|
| Products | |
| Owner | Etienne Jornod (Executive Chairman & Co‑Owner) |
| Website | www.ompharma.com |
OM Pharma is a Swiss biopharmaceutical company headquartered in Geneva. It specializes in the development and commercialization of immunomodulatory treatments, particularly those derived from bacterial origins, aimed at treating respiratory and inflammatory diseases. OM Pharma’s portfolio focuses on addressing chronic respiratory issues and infections by enhancing the body’s immune response through microbial-derived therapies.
In 2020, the company was acquired by Optimus Holding, led by Etienne Jornod, which committed to significant investments in its research and manufacturing capabilities[1].
History
Structure and subsidiaries
Products
References
- ^ PricewaterhouseCoopers. "Vifor Pharma Group announces successful sale of OM Pharma to Optimus Holding Ltd". PwC. Retrieved 2024-10-17.